LLM returned non-JSON response. Review the filing manually.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $90.16entry
- T+1 · 5mo ago −1.53%α −2.31% · $88.78
- T+5 · 4mo ago −1.57%α −2.96% · $88.74
- T+20 · 4mo ago +13.28%α +13.56% · $102.13
- T+60 · 8w ago +2.01%α −2.38% · $91.97
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
{ "summary": "Spyre Therapeutics filed an automatic shelf registration statement (S-3ASR) on June 26, 2026, registering an unlimited amount of securities, and concurrently entered into a $500M at-the-market (ATM) sales agreement with TD Cowen for common stock. The company has a $7.8B market cap, a strong cash position from prior raises, and no disclosed need for immediate capital, making this an opportunistic shelf filing to maintain financial flexibility rather than a distress-driven raise.",
Financial Impact
Unknown
Risk Factors
- Analysis may be incomplete
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3ASR Filing (Primary) | 0001628280-26-045742 |
| Exhibit: exhibit12-sx3asr.htm | 0001628280-26-045742 |
| Exhibit: exfilingfees-s3asr.htm | 0001628280-26-045742 |
| Exhibit: exhibit51-sx3asr.htm | 0001628280-26-045742 |
| Exhibit: exhibit52-sx3asr.htm | 0001628280-26-045742 |
| Exhibit: exhibit232-sx3asr.htm | 0001628280-26-045742 |
| Exhibit: exhibit231-sx3asr.htm | 0001628280-26-045742 |
| Document: spyre-formsx3asrjune2026.htm | 0001628280-26-045742 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers